| |
| |
|
| Insider
Information: |
Thompson Elizabeth H.z. |
| Relationship: |
|
| City: |
Dublin |
| State: |
L2 |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
1,452 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
1,452 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Horizon Pharma, Inc. |
HZNP |
EVP, Research & Develo... |
2023-10-06 |
0 |
|
0 |
Premium* |
|
|
Igm Biosciences, Inc. |
IGMS |
|
2024-03-29 |
1,452 |
2024-03-29 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
15 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| IGMS |
Igm Biosciences, Inc. |
|
– • – |
2024-03-29 |
4 |
A |
$0.00 |
$0 |
D/D |
1,452 |
1,452 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP, Research & Development |
• – – |
2023-10-06 |
4 |
D |
$116.50 |
$1,697,988 |
D/D |
(14,575) |
0 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP, Research & Development |
• – – |
2023-03-13 |
4 |
GD |
$0.00 |
$0 |
D/D |
2,000 |
14,575 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP, Research & Development |
• – – |
2022-12-30 |
4 |
D |
$113.80 |
$1,075,296 |
D/D |
(9,449) |
16,575 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP, Research & Development |
• – – |
2022-12-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
19,055 |
26,024 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP, Research & Development |
• – – |
2022-07-20 |
4 |
AS |
$85.00 |
$502,945 |
D/D |
(5,917) |
6,969 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP, Research & Development |
• – – |
2022-07-19 |
4 |
AS |
$85.02 |
$7,653 |
D/D |
(90) |
12,886 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP, Research & Development |
• – – |
2022-07-07 |
4 |
AS |
$85.01 |
$6,971 |
D/D |
(82) |
12,976 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP, Research & Development |
• – – |
2022-04-18 |
4 |
AS |
$115.64 |
$936,453 |
D/D |
(8,098) |
13,058 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP, Research & Development |
• – – |
2022-01-05 |
4 |
D |
$101.84 |
$715,935 |
D/D |
(7,030) |
21,156 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP, Research & Development |
• – – |
2022-01-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
13,999 |
28,186 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP, Research & Development |
• – – |
2021-08-05 |
4 |
S |
$106.34 |
$802,025 |
D/D |
(7,542) |
14,187 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP, Research & Development |
• – – |
2021-07-01 |
4 |
D |
$96.59 |
$578,381 |
D/D |
(5,988) |
21,729 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP, Research & Development |
• – – |
2021-07-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
12,077 |
27,717 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP, Research & DevelopmentOff |
• – – |
2021-04-29 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
15,640 |
|
- |
|
15 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
